Upendra Kumar Soni

Employment

Employment history is unavailable.

Education

• Central Drug Research Institute PhD
  2016 - Present

Projects & Funding

Projects & funding information is unavailable.

Publications (30)

• Figure S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706289
  +Save
• Figure S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706292
  +Save
• Table S2 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706265
  +Save
• Table S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706268
  +Save
• Supplementary Data File S1 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706271
  +Save
• Figure S6 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706277
  +Save
• Figure S5 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706280
  +Save
• Figure S4 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706283
  +Save
• Figure S3 from Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  2025 DOI: 10.1158/1078-0432.30706286
  +Save
• Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition
  Clinical Cancer Research 2023 DOI: 10.1158/1078-0432.CCR-22-2587
  +Save